Inflammatory cell microlocalisation and airway dysfunction: cause and effect?

Siddiqui S., Hollins F., Saha S., Brightling C. E.

Source: Eur Respir J 2007; 30: 1043-1056
Journal Issue: December
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Siddiqui S., Hollins F., Saha S., Brightling C. E.. Inflammatory cell microlocalisation and airway dysfunction: cause and effect?. Eur Respir J 2007; 30: 1043-1056

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical relevance of airway remodelling in airway diseases
Source: Eur Respir J 2007; 30: 134-155
Year: 2007



Current perspectives in epithelial cell injury and repair: consequences for epithelial functions
Source: Eur Respir Rev 2005; 14: 126-130
Year: 2005



The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease
Source: International Congress 2014 – Cell biology 2014
Year: 2014

What is new in chronic obstructive pulmonary disease?
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=153
Year: 2007

Multiple inflammatory hits and the pathogenesis of severe airway disease
Source: Eur Respir J 2006; 27: 884-888
Year: 2006



Tools used to measure airway remodelling in research
Source: Eur Respir J 2007; 29: 596-604
Year: 2007



The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Pulmonary vascular involvement in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 28S-32S
Year: 2003



Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016


Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010

Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013


Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008



Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003



Chronic obstructive pulmonary disease and cardiac remodeling: gender aspect.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018



Systemic effects of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224
Year: 2006

Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011


Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 325-331
Year: 2002